Clinical Trial Update: A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating disitamab vedotin in adults with HER2-expressing advanced breast cancer is currently recruiting (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer, Breast Neoplasms | Phase 1, Phase 2 | Status: RECRUITING